ZCA
SSKN

Zeke Capital Advisors’s Strata Skin Sciences SSKN Stock Holding History

Zeke Capital Advisors’s Portfolio SSKN Stock Details SSKN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-27
Closed -$4K – 68
2014
Q2 		$4K Buy
+27
New +$6.12K ﹤0.01% 67

Other funds holding SSKN

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
AH
Allen Holding New York $1.01B AUM 27.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TH
Timber Hill Greenwich, Connecticut $15.4M AUM 30.7% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Zeke Capital Advisors's SSKN Position: Q3 2014 in Review

Zeke Capital Advisors sold out of Strata Skin Sciences (SSKN) in Q3 2014, closing a stake of 27 shares — an estimated $4K sold.

Zeke Capital Advisors first reported a position in SSKN in Q2 2014 and held it in 1 quarter. The position peaked at $4K in Q2 2014. 22 funds tracked by Wall St. Rank hold SSKN as of Q3 2014.

  • Zeke Capital Advisors reported no remaining Strata Skin Sciences position as of Q3 2014 after selling out during the quarter.
  • Zeke Capital Advisors sold 27 Strata Skin Sciences shares in Q3 2014, an estimated $4K.
  • Zeke Capital Advisors first reported a position in Strata Skin Sciences in Q2 2014 and held it in 1 quarter.
  • Zeke Capital Advisors's Strata Skin Sciences position peaked at $4K in Q2 2014.
  • 22 funds tracked by Wall St. Rank held Strata Skin Sciences as of Q3 2014.

Based on Zeke Capital Advisors's 13F filing for Q3 2014, filed 13 Nov 2014.